Pricing Log in Create free account

Attovia Therapeutics, Inc. (ATTO) vs Sagimet Biosciences Inc. (SGMT)

Attovia Therapeutics, Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. Attovia Therapeutics, Inc. and Sagimet Biosciences Inc. are of similar size ($802.6M and $764.8M). Across the 3 metrics below, Attovia Therapeutics, Inc. leads on 2 and Sagimet Biosciences Inc. on 1.

Valuation

Metric ATTO SGMT Biotechnology median
P/E — n/m 11.58
P/S n/m n/m 9.61
P/B n/m 2.35 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield — (11.30%) (32.28%)
Free cash flow yield 0.00% (6.93%) (22.27%)

Profitability

Metric ATTO SGMT Biotechnology median
Gross margin — 0.00% 68.81%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — (24.37%) (50.30%)
Return on assets — (23.49%) (45.47%)
Return on invested capital 0.00% (205.24%) 0.00%

Growth

Metric ATTO SGMT Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) — (8.97%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ATTO SGMT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.39 45.02 4.74
Net debt to EBITDA — 1.98 1.01

Dividend

Metric ATTO SGMT Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ATTO SGMT Biotechnology median
Market cap 764.77m 802.59m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack